Methodological differences between pharmacological treatment guidelines for bipolar disorder: what to do for the clinicians?

Overview of attention for article published in Comprehensive Psychiatry, November 2012

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 1 X user

guideline: 1 clinical guideline source

Readers on

mendeley: 70 Mendeley

So far, Altmetric has seen 3 Guidelines that reference this research output.

French Society for Biological Psychiatry and Neuropsychopharmacology (AFPBN) guidelines for the management of patients with partially responsive depression and treatment-resistant depression: Update 2024

Clinical guideline published by Association Française de Psychiatrie Biologique et Neuropsychopharmacologie (AFBPN) on 17 Feb 2024

The Association Française de Psychiatrie Biologique et Neuropsychopharmacologie (AFBPN) was founded in 1979 by Professor Pierre Deniker with the aim of promoting the scientific study of psychiatric conditions, their prevention, and their treatment.

Prise en charge des troubles dépressifs résistants : recommandations françaises formalisées par des experts de l’AFPBN et de la fondation FondaMental

Clinical guideline published by Association Française de Psychiatrie Biologique et Neuropsychopharmacologie (AFBPN) on 01 Sep 2017

Recommandations Formalisées d’Experts de l’Association Française de Psychiatrie Biologique et Neuropsychopharmacologie sur le dépistage et prise en charge du trouble bipolaire : mise à jour 2014

Clinical guideline published by Association Française de Psychiatrie Biologique et Neuropsychopharmacologie (AFBPN) on 26 Dec 2014

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.